Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43

Immune checkpoint therapies (ICT) have achieved unprecedented efficacy in multiple cancer treatments, but are still limited by low clinical response rates. Identification of immunogenic cell death (ICD)‐inducing drugs that can induce tumor cell immunogenicity and reprogram the tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Mingxiao, Dong, Jingwen, Sun, Cuicui, Liu, Xiaojia, Liu, Zhirui, Liu, Lu, Kuang, Zean, Zhang, Na, Xiao, Dian, Zhou, Xinbo, Deng, Hongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161045/
https://www.ncbi.nlm.nih.gov/pubmed/36876644
http://dx.doi.org/10.1002/advs.202206737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161045/
https://www.ncbi.nlm.nih.gov/pubmed/36876644
http://dx.doi.org/10.1002/advs.202206737

Ejemplares similares